LU91452I2 - "Mycafungine et ses sels pharmaceutiquement acceptables(MYCAMINEr)" - Google Patents
"Mycafungine et ses sels pharmaceutiquement acceptables(MYCAMINEr)"Info
- Publication number
- LU91452I2 LU91452I2 LU91452C LU91452C LU91452I2 LU 91452 I2 LU91452 I2 LU 91452I2 LU 91452 C LU91452 C LU 91452C LU 91452 C LU91452 C LU 91452C LU 91452 I2 LU91452 I2 LU 91452I2
- Authority
- LU
- Luxembourg
- Prior art keywords
- mycaminer
- mycafungin
- pharmaceutically acceptable
- acceptable salts
- salts
- Prior art date
Links
- 150000003839 salts Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/50—Cyclic peptides containing at least one abnormal peptide link
- C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
- C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9420425A GB9420425D0 (en) | 1994-10-07 | 1994-10-07 | New compound |
GBGB9508745.8A GB9508745D0 (en) | 1995-04-28 | 1995-04-28 | New compound |
PCT/JP1995/001983 WO1996011210A1 (fr) | 1994-10-07 | 1995-09-29 | Hexapeptides cycliques a activite antibiotique |
Publications (1)
Publication Number | Publication Date |
---|---|
LU91452I2 true LU91452I2 (fr) | 2008-08-04 |
Family
ID=26305774
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LU91452C LU91452I2 (fr) | 1994-10-07 | 2008-06-04 | "Mycafungine et ses sels pharmaceutiquement acceptables(MYCAMINEr)" |
Country Status (27)
Country | Link |
---|---|
US (2) | US6107458A (fr) |
EP (1) | EP0788511B1 (fr) |
JP (2) | JP2897427B2 (fr) |
KR (1) | KR100353303B1 (fr) |
CN (1) | CN1203089C (fr) |
AR (1) | AR041770A1 (fr) |
AT (1) | ATE229541T1 (fr) |
AU (1) | AU696949B2 (fr) |
BR (2) | BRPI9504791B8 (fr) |
CA (1) | CA2202058C (fr) |
DE (2) | DE69529172T2 (fr) |
DK (1) | DK0788511T3 (fr) |
ES (1) | ES2187575T3 (fr) |
FI (1) | FI119988B (fr) |
FR (1) | FR08C0028I2 (fr) |
HK (1) | HK1004136A1 (fr) |
HU (1) | HU228151B1 (fr) |
IL (1) | IL115484A (fr) |
LU (1) | LU91452I2 (fr) |
MX (1) | MX9702531A (fr) |
NL (1) | NL300352I2 (fr) |
NO (2) | NO328483B1 (fr) |
OA (1) | OA10475A (fr) |
PT (1) | PT788511E (fr) |
RU (1) | RU2165423C2 (fr) |
TR (1) | TR199501229A2 (fr) |
WO (1) | WO1996011210A1 (fr) |
Families Citing this family (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5696084A (en) * | 1996-08-16 | 1997-12-09 | Abbott Laboratories | Amino-lipopetide antifungal agents |
AUPO371596A0 (en) * | 1996-11-19 | 1996-12-12 | Fujisawa Pharmaceutical Co., Ltd. | New compound |
AUPO381496A0 (en) * | 1996-11-25 | 1996-12-19 | Fujisawa Pharmaceutical Co., Ltd. | New compound |
US6291680B1 (en) * | 1997-06-18 | 2001-09-18 | Fujisawa Pharmaceutical Co., Ltd. | Production process |
AU756792B2 (en) * | 1998-02-09 | 2003-01-23 | Fujisawa Pharmaceutical Co., Ltd. | New compound |
EP1053247A1 (fr) * | 1998-02-09 | 2000-11-22 | Fujisawa Pharmaceutical Co., Ltd. | Nouveau compose |
US7084279B1 (en) * | 1999-02-11 | 2006-08-01 | Emisphere Technologies Inc. | Oxadiazole compounds and compositions for delivering active agents |
ATE311373T1 (de) * | 1999-02-11 | 2005-12-15 | Emisphere Tech Inc | Oxadiazolverbindungen und -zusammensetzungen zur abgabe von wirkstoffen |
AUPP999799A0 (en) | 1999-04-27 | 1999-05-20 | Fujisawa Pharmaceutical Co., Ltd. | New compound |
AUPQ066399A0 (en) * | 1999-05-31 | 1999-06-24 | Fujisawa Pharmaceutical Co., Ltd. | Antifungal combination use |
TWI233805B (en) * | 1999-07-01 | 2005-06-11 | Fujisawa Pharmaceutical Co | Stabilized pharmaceutical composition in lyophilized form as antifungal agent |
US7166572B1 (en) | 1999-07-27 | 2007-01-23 | Aventis Pharma Deutschland Gmbh | Cyclohexapeptide compounds, processes for their production and their use as a pharmaceutical |
AUPQ462399A0 (en) * | 1999-12-13 | 2000-01-13 | Fujisawa Pharmaceutical Co., Ltd. | New use |
TWI250992B (en) | 2000-02-21 | 2006-03-11 | Astellas Pharma Inc | Polypeptide compounds for the prophylactic and/or therapeutic treatment of infectious diseases caused by pathogenic microorganisms |
ES2191516B1 (es) * | 2000-07-28 | 2005-01-01 | Consejo Superior De Investigaciones Cientificas | Antibioticos antifungicos de naturaleza peptidica inhibidores de la germinacion y el crecimiento de hongos fitopatogenos. |
AUPQ938700A0 (en) * | 2000-08-14 | 2000-09-07 | Fujisawa Pharmaceutical Co., Ltd. | Antifungal combination use |
DE60234812D1 (de) | 2001-01-29 | 2010-02-04 | Shionogi & Co | Arzneipräparat, das als wirkstoff 5-methyl-1-phenyl-2-(1h)-pyridon enthält |
JP2005053782A (ja) * | 2001-08-31 | 2005-03-03 | Fujisawa Pharmaceut Co Ltd | 環状リポペプチド化合物の新規結晶 |
AU2003217676B2 (en) | 2002-02-22 | 2009-06-11 | Takeda Pharmaceutical Company Limited | Active agent delivery systems and methods for protecting and administering active agents |
WO2004014879A1 (fr) * | 2002-08-08 | 2004-02-19 | Fujisawa Pharmaceutical Co., Ltd. | Procede de preparation d'acides isoxazolyle-benzoiques |
AU2003903205A0 (en) * | 2003-06-23 | 2003-07-10 | Fujisawa Pharmaceutical Co., Ltd. | New compound |
ATE381957T1 (de) * | 2003-07-22 | 2008-01-15 | Theravance Inc | Verwendung eines antimykotischen echinocandin- mittels in kombination mit einem antibakteriellen glycopeptid-mittel |
CA2537574A1 (fr) * | 2003-09-05 | 2005-03-24 | Merck & Co., Inc. | Phases stationnaires et procede de purification mettant en oeuvre lesdites phases |
US7547693B2 (en) * | 2003-09-22 | 2009-06-16 | Banyu Pharmaceutical Co. Ltd. | Piperidine derivative |
US7476673B2 (en) * | 2003-12-30 | 2009-01-13 | Allergan, Inc. | Disubstituted chalcone oximes as selective agonists of RARγ retinoid receptors |
EP1768968A1 (fr) * | 2004-05-20 | 2007-04-04 | Foldrx Pharmaceuticals, Inc. | Composes 2-(heteroaryl)benzoxazoles et derives, compositions et procedes servant a stabiliser la transthyretine et a inhiber le mauvais repliement de la transthyretine |
MX2007003325A (es) | 2004-09-20 | 2007-06-05 | Xenon Pharmaceuticals Inc | Derivados heterociclicos y su uso como inhibidores estearoil-coa-desaturasa. |
AU2005286728A1 (en) | 2004-09-20 | 2006-03-30 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as mediators of stearoyl-CoA desaturase |
EP1804799B1 (fr) | 2004-09-20 | 2013-08-21 | Xenon Pharmaceuticals Inc. | Dérivés hétérocycliques et leur utilisation en tant qu'agents thérapeutiques |
AU2005286793A1 (en) | 2004-09-20 | 2006-03-30 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-CoA desaturase enzymes |
AU2005286731A1 (en) | 2004-09-20 | 2006-03-30 | Xenon Pharmaceuticals Inc. | Pyridazine derivatives for inhibiting human stearoyl-CoA-desaturase |
CA2580856A1 (fr) | 2004-09-20 | 2006-03-30 | Xenon Pharmaceuticals Inc. | Derives heterocycliques et leur utilisation en tant qu'inhibiteurs de la stearoyl-coa desaturase |
US7777036B2 (en) | 2004-09-20 | 2010-08-17 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as therapeutic agents |
EP1815206B1 (fr) * | 2004-10-13 | 2016-04-06 | PTC Therapeutics, Inc. | Composes de suppression de non-sens et procedes de leur utilisation |
EP2029138A1 (fr) | 2005-06-03 | 2009-03-04 | Xenon Pharmaceuticals Inc. | Derives aminothiazole utilises en tant qu'inhibiteurs de la stearoyle-coa desaturase humaine |
US7947707B2 (en) * | 2005-10-07 | 2011-05-24 | Kissei Pharmaceutical Co., Ltd. | Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same |
CN101516387B (zh) * | 2006-07-26 | 2014-06-04 | 桑多斯股份公司 | 卡泊芬净制剂 |
US8853392B2 (en) | 2007-06-03 | 2014-10-07 | Vanderbilt University | Benzamide mGluR5 positive allosteric modulators and methods of making and using same |
CA2699980C (fr) | 2007-08-13 | 2015-06-02 | Divergence, Inc. | Compositions et procedes pour lutter contre les nematodes |
CN101861330A (zh) * | 2007-10-29 | 2010-10-13 | 安斯泰来制药有限公司 | 多肽化合物 |
US8034806B2 (en) | 2007-11-02 | 2011-10-11 | Vanderbilt University | Bicyclic mGluR5 positive allosteric modulators and methods of making and using same |
AU2009271328B2 (en) * | 2008-06-24 | 2012-09-06 | Irm Llc | Compounds and methods for modulating G protein-coupled receptors |
US9394340B2 (en) | 2009-03-24 | 2016-07-19 | Cadila Healthcare Limited | Purification process for lipopeptides |
BR112013023531A2 (pt) * | 2011-04-04 | 2016-12-06 | Xellia Pharmaceuticals Aps | processo de um único vaso para a fabricação de micafungina ou de um sal desta |
SI2699327T1 (sl) | 2011-04-20 | 2015-11-30 | Xelia Pharmaceuticals Aps | Postopek čiščenja mikafungina |
CN102775476B (zh) * | 2011-05-12 | 2015-01-07 | 上海天伟生物制药有限公司 | 一种米卡芬净钠盐的制备方法 |
EP2709609B1 (fr) | 2011-05-17 | 2017-10-04 | Shionogi & Co., Ltd. | Composés hétérocycliques |
HUE029720T2 (en) | 2011-09-09 | 2017-03-28 | Sandoz Ag | Preparation of micafungin intermediates |
CN102659930B (zh) * | 2012-03-30 | 2014-04-23 | 上海天伟生物制药有限公司 | 一种高纯度环肽类物质的晶体及其制备方法和用途 |
CN102627689B (zh) * | 2012-03-30 | 2014-08-06 | 上海天伟生物制药有限公司 | 一种环肽类化合物的水合物及其制备方法和用途 |
CN102627688B (zh) | 2012-03-30 | 2014-12-31 | 上海天伟生物制药有限公司 | 一种高纯度环肽化合物及其制备方法和用途 |
JP6491325B2 (ja) * | 2014-05-29 | 2019-03-27 | シャンハイ テックウェル バイオファーマシューティカル カンパニー リミテッドShanghai Techwell Biopharmaceutical Co.,Ltd | シクロペプチド系化合物の溶媒和物およびその製造方法と使用 |
WO2016056023A2 (fr) * | 2014-10-07 | 2016-04-14 | Alaparthi Lakshmi Prasad | Produits intermédiaires et procédés de préparation de micafungine |
CA2937365C (fr) | 2016-03-29 | 2018-09-18 | F. Hoffmann-La Roche Ag | Formulation en granules de 5-methyl-1-phenyl-2-(1h)-pyridone et methode de fabrication associee |
EP3485873A1 (fr) | 2017-11-17 | 2019-05-22 | Cadila Healthcare Limited | Compositions injectables pharmaceutiques stables de micafungine |
CN108752430B (zh) * | 2018-05-31 | 2022-02-18 | 杭州中美华东制药有限公司 | 米卡芬净钠新晶型及其制备方法 |
WO2020013116A1 (fr) * | 2018-07-10 | 2020-01-16 | 京都薬品工業株式会社 | Inhibiteur de ptp-1b et son utilisation |
CN110734408A (zh) * | 2019-10-22 | 2020-01-31 | 重庆康乐制药有限公司 | 一种米卡芬净类衍生物侧链中间体的制备方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE990233A1 (en) * | 1990-06-18 | 2000-11-15 | Fujisawa Pharmaceutical Co | New Polypeptide Compound and a Process for Preparation thereof |
TW264477B (fr) * | 1992-03-19 | 1995-12-01 | Lilly Co Eli |
-
1995
- 1995-09-29 US US08/809,723 patent/US6107458A/en not_active Expired - Lifetime
- 1995-09-29 RU RU97107338/04A patent/RU2165423C2/ru active Protection Beyond IP Right Term
- 1995-09-29 KR KR1019970702213A patent/KR100353303B1/ko not_active IP Right Cessation
- 1995-09-29 PT PT95932935T patent/PT788511E/pt unknown
- 1995-09-29 MX MX9702531A patent/MX9702531A/es unknown
- 1995-09-29 EP EP95932935A patent/EP0788511B1/fr not_active Expired - Lifetime
- 1995-09-29 AU AU35780/95A patent/AU696949B2/en not_active Expired
- 1995-09-29 HU HU9800338A patent/HU228151B1/hu active Protection Beyond IP Right Term
- 1995-09-29 JP JP8512472A patent/JP2897427B2/ja not_active Expired - Lifetime
- 1995-09-29 CN CNB95196643XA patent/CN1203089C/zh not_active Expired - Lifetime
- 1995-09-29 AT AT95932935T patent/ATE229541T1/de active
- 1995-09-29 WO PCT/JP1995/001983 patent/WO1996011210A1/fr active IP Right Grant
- 1995-09-29 CA CA002202058A patent/CA2202058C/fr not_active Expired - Lifetime
- 1995-09-29 DK DK95932935T patent/DK0788511T3/da active
- 1995-09-29 ES ES95932935T patent/ES2187575T3/es not_active Expired - Lifetime
- 1995-09-29 DE DE69529172T patent/DE69529172T2/de not_active Expired - Lifetime
- 1995-09-29 DE DE122008000025C patent/DE122008000025I2/de active Active
- 1995-10-02 IL IL11548495A patent/IL115484A/xx not_active IP Right Cessation
- 1995-10-06 BR BRPI9504791A patent/BRPI9504791B8/pt unknown
- 1995-10-06 AR ARP9501333763A patent/AR041770A1/es unknown
- 1995-10-06 BR BRPI9504791-3A patent/BR9504791B1/pt active IP Right Grant
- 1995-10-06 TR TR95/01229A patent/TR199501229A2/xx unknown
-
1997
- 1997-04-04 NO NO19971544A patent/NO328483B1/no not_active IP Right Cessation
- 1997-04-04 FI FI971397A patent/FI119988B/fi not_active IP Right Cessation
- 1997-04-17 OA OA60989A patent/OA10475A/en unknown
-
1998
- 1998-04-28 HK HK98103576A patent/HK1004136A1/xx not_active IP Right Cessation
- 1998-05-19 JP JP13675698A patent/JP3518665B2/ja not_active Expired - Lifetime
-
1999
- 1999-02-11 US US09/248,267 patent/US6265536B1/en not_active Expired - Lifetime
-
2008
- 2008-06-03 NL NL300352C patent/NL300352I2/nl unknown
- 2008-06-04 LU LU91452C patent/LU91452I2/fr unknown
- 2008-06-27 FR FR08C0028C patent/FR08C0028I2/fr active Active
-
2010
- 2010-08-09 NO NO2010016C patent/NO2010016I2/no unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LU91452I2 (fr) | "Mycafungine et ses sels pharmaceutiquement acceptables(MYCAMINEr)" | |
LU91291I2 (fr) | Deferasirox et ses sels pharmaceutiquement acceptables (EXJADEr) | |
NL300952I2 (nl) | Peramivir en farmaceutisch aanvaardbare zouten daarvan | |
LU90736I2 (fr) | Agenerase-amprenavir et ses d-riv-s pharmaceutiquement acceptables | |
LU91147I2 (fr) | Pemetrexed et ses sels pharmaceutiquement acceptables. | |
LU91076I2 (fr) | Tulathromycin et ses sels pharmaceutiquement acceptables (draxxin). | |
LU91673I2 (fr) | "Dronédarone et ses dérivés pharmaceutiquement acceptables (MULTAQ)" | |
LU91345I2 (fr) | Rufinamide et ses sels pharmaceutiquement acceptables (inovelon) | |
LU91437I2 (fr) | "dabigatran-etexilate et ses sels- particulièrement dabigatran-etexilate-mésilate (PRADAXA)" | |
LU90829I2 (fr) | Tepoxalin-zubrin et ses d-riv-s pharmaceutiquement acceptables | |
LU91205I2 (fr) | Ciclesonide et ses dérivés pharmaceutiquement acceptables (alvesco) | |
LU91655I2 (fr) | Corifollitropine alfa et ses dérivés pharmaceutiquement acceptables (ELONVA®) | |
MC2263A1 (fr) | Aminobenzodiazepines et leurs sels pharmaceutiquement acceptables | |
LU90844I2 (fr) | es Riamet et ses d-riv-s pharmaceutiquement acceptabl | |
LU92564I2 (fr) | Médocaril de ceftobiprole et les sels pharmaceutiquement acceptables qui en dérivent | |
DK0821692T3 (da) | Immunopotenserende inosinmonophosphat-5'-nukleotidasemodstandsdygtige derivater og anvendelser deraf | |
ITGE940099A0 (it) | Dispositivo per l'agugliatura di una falda di ovatta. | |
ITMI962503A0 (it) | Procedimento per progettare una apparecchiatura impiegante superconduttivita' e apparecchiatura impiegante superconduttivita' | |
KR940005143U (ko) | 유희용 라켓 | |
LU90110I2 (fr) | Penciclovir et ses dérivés pharmaceutiquement acceptables | |
ITGE940106A0 (it) | Dispositivo per l'agugliatura di una falda di ovatta. | |
KR940001899U (ko) | 네온 변압기의 접속구 | |
KR960038365U (ko) | 피엘씨의 입출력 증설장치 | |
ZA937286B (en) | Immunopotentiatory agents and physiologically acceptable salts thereof | |
GB9226874D0 (en) | Immunopotentiatory agents and physiologically acceptable salts thereof |